Unknown

Dataset Information

0

Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.


ABSTRACT: Chimeric antigen receptor (CAR) T-cell therapy is a new successful treatment for refractory B-cell leukemia. Successful therapeutic outcome depends on long-term expression of CAR transgene in T cells, which is achieved by delivering transgene using integrating gamma retrovirus (RV) or lentivirus (LV). However, uncontrolled RV/LV integration in host cell genomes has the potential risk of causing insertional mutagenesis. Herein, we describe a novel episomal long-term cell engineering method using non-integrating lentiviral (NILV) vector containing a scaffold/matrix attachment region (S/MAR) element, for either expression of transgenes or silencing of target genes. The insertional events of this vector into the genome of host cells are below detection level. CD19 CAR T cells engineered with a NILV-S/MAR vector have similar levels of CAR expression as T cells engineered with an integrating LV vector, even after numerous rounds of cell division. NILV-S/MAR-engineered CD19 CAR T cells exhibited similar cytotoxic capacity upon CD19(+) target cell recognition as LV-engineered T cells and are as effective in controlling tumor growth in vivo We propose that NILV-S/MAR vectors are superior to current options as they enable long-term transgene expression without the risk of insertional mutagenesis and genotoxicity.

SUBMITTER: Jin C 

PROVIDER: S-EPMC4931286 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.

Jin Chuan C   Fotaki Grammatiki G   Ramachandran Mohanraj M   Nilsson Berith B   Essand Magnus M   Yu Di D  

EMBO molecular medicine 20160701 7


Chimeric antigen receptor (CAR) T-cell therapy is a new successful treatment for refractory B-cell leukemia. Successful therapeutic outcome depends on long-term expression of CAR transgene in T cells, which is achieved by delivering transgene using integrating gamma retrovirus (RV) or lentivirus (LV). However, uncontrolled RV/LV integration in host cell genomes has the potential risk of causing insertional mutagenesis. Herein, we describe a novel episomal long-term cell engineering method using  ...[more]

Similar Datasets

| S-EPMC3987883 | biostudies-literature
| S-EPMC4491658 | biostudies-literature
| S-EPMC6637939 | biostudies-literature
2019-02-11 | GSE102823 | GEO
| S-EPMC6554529 | biostudies-literature
| S-EPMC7518381 | biostudies-literature
| S-EPMC8425252 | biostudies-literature
| S-EPMC3720863 | biostudies-literature
| S-EPMC7349724 | biostudies-literature
| S-EPMC8412433 | biostudies-literature